MedPath

Magnetomotoric Ultrasound (MMUS) in Rectal Cancer

Not Applicable
Recruiting
Conditions
Rectal Cancer
Interventions
Diagnostic Test: Magnetomotoric ultrasound
Registration Number
NCT05052086
Lead Sponsor
Region Skane
Brief Summary

Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. The aim is to improve diagnosis of mesolectal lymph nodes.

Detailed Description

Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. Nanoparticles are injected close to the rectal cancer and migrate to adjacent lymph nodes.The time-varying magnetic field will influence the nano particles in the lymph node enhancing diagnosis of affected lymph nodes. The aim is to improve diagnosis of mesolectal lymph nodes and compare the results of magnetomotoric ultrasound with MRI and final histopathology.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Rectal cancer
  • Scheduled for total mesorectal surgery
  • Informed consent
Exclusion Criteria
  • Not able to give informed consent
  • Synchronus colorectal cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Magnetomotoric ultrasoundMagnetomotoric ultrasoundMagnetomotoric ultrasound in addition to MRI.
Primary Outcome Measures
NameTimeMethod
Accuracy of mesorectal lymph node diagnosis with MMUS, compared with final histopathologyApproximately 1 hour after MMUS

Evaluation of the accuracy of MMUS in detecting lymph node metastases in rectal cancer. The results of the MMUS (malignant or benign lymph nodes) will be compared with final histopathology. The accuracy will be expressed in sensitivity (%), specificity (%) and overall accuracy (% correctly staged lymph nodes with MMUS)

Accuracy of mesorectal lymph node diagnosis with MMUS, compared with preoperative MRIApproximately 1 hour after MMUS

Evaluation of the accuracy of MMUS in detecting lymph node metastases in rectal cancer in comparison to standard staging (MRI). The results of the MMUS (malignant nodes or benign nodes) will be compared with the results of preoperative MRI (malignant or benign lymph nodes) and the final histopathology. The accuracy will be expressed in sensitivity (%), specificity (%) and overall accuracy (% correctly staged lymph nodes) with MMUS and MRI.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Skane University Hospital, Malmö, section of Surgery

🇸🇪

Malmö, Skåne, Sweden

© Copyright 2025. All Rights Reserved by MedPath